ArticleTheranostics2019

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5.

Sandy Giuliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.